3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
1
Surgery
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Ductal Adenocarcinoma
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Multiple Myeloma
1
Medulloblastoma
1
Lung Neoplasms
1
Liposarcoma
1
Leiomyosarcoma
1
HER2-positive Breast Cancer
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Cancer Invasive
1
Interventions
Gemcitabine
5
Cisplatin
5
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Leucovorin
4
Fluorouracil
4
durvalumab
3
Taxes
3
futibatinib
2
fludarabine
2
Specimen Handling
2
Platinum
2
Paclitaxel
2
Nivolumab
2
Irinotecan
2
Folfox protocol
2
Fluorodeoxyglucose F18
2
Carboplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
zimberelimab
1
ulixertinib
1
tocilizumab
1
tivozanib
1
tislelizumab
1
regorafenib
1
pevonedistat
1
pemigatinib
1
pembrolizumab
1
olutasidenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cholangiocarcinoma
×
Neoadjuvant Therapy
×
30 days
×
Clear all
No trials found.